Mannkind vs Pharming Group
Mannkind and Pharming Group are similar in size: $349m and $376m of revenue in their latest fiscal years. Pharming Group grew faster (26.6% against 22.2%). Mannkind kept more of each dollar of sales as profit: a net margin of 1.7% against 0.8%.
| Latest fiscal year | MannkindMNKD, 2025 | Pharming GroupPHAR, 2025 |
|---|---|---|
| Revenue | $349m | $376m |
| Revenue growth | 22.2% | 26.6% |
| Net income | $5.9m | $2.9m |
| Operating margin | 11.1% | 6.9% |
| Net margin | 1.7% | 0.8% |
| Return on equity | — | 1.1% |
| Free cash flow | $13.7m | $54.0m |
| Cash | $74.9m | $145m |
| Total debt | $361m | $98.1m |
| Debt to equity | — | 35.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $1.16bn | $898m |
| Price vs our value range | — | Above our value range |
| Moat score | 20 (Weak) | — |
| Insider trades, 12 months | 1 buys, 14 sales | 0 buys, 0 sales |